The new molecule – called DSP-0038 – is being developed by Japan's Sumitomo Dainippon Pharma (DSP), which is now starting a phase 1 trial in the US as a treatment for psychosis associated with ...

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies ...

Dainippon Sumitomo Pharma (DSP), and Evotec. Those deals had already made Exscientia one of the most well-funded players in the AI drug discovery category even before it closed a $510 million ...

Sumitomo Mitsui Financial is poised for growth with an improving NIM, a 10% profit boost by FY 2026. Click here to read why ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Forbes does not accept payment for placement on lists.

2802.T Ajinomoto Co., Inc.

At close: February 10 at 3:59:09 PM EST ...